You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

CAR-T Therapy

Showing 9976 - 10000 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Prospective Study of White Blood Cells

Recruiting
  • Autoimmune Diseases
  • +2 more
  • White blood cell and blood collection
  • London, United Kingdom
    Quell Investigator Site 01
Apr 6, 2021

Hypertension Trial in Split (Cannabidiol, Placebo)

Active, not recruiting
  • Hypertension
  • Cannabidiol
  • Placebo
  • Split, Croatia
    University of Split School of medicine
Apr 25, 2022

Breast Cancer, DCIS Trial in Canada (APBI: 30 Gy, APBI: 27.5 Gy)

Active, not recruiting
  • Breast Cancer
  • DCIS
  • APBI: 30 Gy
  • APBI: 27.5 Gy
  • Barrie, Ontario, Canada
  • +9 more
Apr 4, 2022

De Novo Kidney Transplant Patients Trial in China (ATG-F)

Completed
  • De Novo Kidney Transplant Patients
  • Beijing, China
  • +13 more
Jul 26, 2022

Childhood Cancer Trial in Saint Louis (EHR-based CDS Alert System for Sensory Deficit Screening)

Not yet recruiting
  • Childhood Cancer
  • EHR-based CDS Alert System for Sensory Deficit Screening
  • Saint Louis, Missouri
    St. Louis Children's Hospital - Washington University School of
Oct 17, 2022

Vaginal Stenosis, Radiation Therapy, Cancer Trial (Vingal Dilator Therapy by Hyivy device)

Not yet recruiting
  • Vaginal Stenosis
  • +2 more
  • Vingal Dilator Therapy by Hyivy device
  • (no location specified)
Jan 5, 2023

Kalydeco on Upper Airway and Paranasal Sinus Inflammation

Completed
  • Inflammatory Changes in Epithelial Lining Fluid Sampled Non-invasively by Nasal Lavage in CF Patients With G551D Receiving Kalydeco
  • nasal lavage (routine diagnostic procedure in our centre), assessment of symptoms
  • Jena, Germany
    Jena University Hospital, CF Center
Jul 8, 2021

Resectable Intrahepatic Cholangiocarcinoma, Stage 0 Intrahepatic Cholangiocarcinoma AJCC v8, Stage I Intrahepatic

Not yet recruiting
  • Resectable Intrahepatic Cholangiocarcinoma
  • +4 more
  • Atlanta, Georgia
  • +2 more
Aug 19, 2022

Alzheimer, Early Onset, Mild Cognitive Impairment Trial in Winston-Salem (Dasatinib + Quercetin, Placebo Capsules)

Recruiting
  • Alzheimer Disease, Early Onset
  • Mild Cognitive Impairment
  • Dasatinib + Quercetin
  • Placebo Capsules
  • Winston-Salem, North Carolina
    Wake Forest Health Sciences
Jan 21, 2022

Tobacco Use Cessation Trial (MindCotine Virtual reality)

Not yet recruiting
  • Tobacco Use Cessation
  • MindCotine Virtual reality
  • (no location specified)
Aug 28, 2023

Mucositis Trial in Pittsburgh (Low Level Laser Therapy)

Completed
Has Results
  • Mucositis
  • Low Level Laser Therapy
  • Pittsburgh, Pennsylvania
    UPMC Shadyside Department of Radiation Oncology
Apr 12, 2022

Mucopolysaccharidosis II Trial (Autologous CD34+ HSCs transduced ex vivo with CD11B LV encoding human IDS tagged with ApoEII)

Not yet recruiting
  • Mucopolysaccharidosis II
  • Autologous CD34+ HSCs transduced ex vivo with CD11B LV encoding human IDS tagged with ApoEII
  • (no location specified)
Dec 16, 2022

Malaria Trial in Goyang-si, Seoul (Pyronaridine - artesunate, Chloroquine)

Terminated
Has Results
  • Malaria
  • Goyang-si, Korea, Republic of
  • +1 more
Nov 18, 2021

Peri-implant Mucositis Trial in Catania (Non surgical peri-implant mucositis therapy with one-stage full-mouth scaling, Non

Recruiting
  • Peri-implant Mucositis
  • Non surgical peri-implant mucositis therapy with one-stage full-mouth scaling
  • Non surgical peri-implant mucositis therapy with one-stage full-mouth scaling and chlorexidine
  • Catania, Italy
    AOU Policlinico G. Rodolico
Jan 31, 2023

Assess Real-World Patient-Reported Outcomes With Fedratinib for

Recruiting
  • Myelofibrosis
    • City, State, Austria
      Local Institution
    Dec 16, 2022

    Gastroparesis, Diabetes Trial in Worldwide (Placebo, Relamorelin)

    Terminated
    Has Results
    • Gastroparesis
    • Diabetes Mellitus
    • Athens, Alabama
    • +239 more
    Jul 15, 2021

    Essential Hypertension Trial in Bucheon-si (Fimasartan + Indapamide, Fimasartan + Indapamide )

    Recruiting
    • Essential Hypertension
    • Fimasartan + Indapamide
    • Fimasartan + Indapamide placebo
    • Bucheon-si, Kyunggi-do, Korea, Republic of
      The Catholic University of Korea, Bucheon St.Mary's Hospital
    May 18, 2023

    Syncope Trial in Medellin, Medellín (Pacemaker with Closed Loop Stimulation (CLS))

    Completed
    • Syncope
    • Pacemaker with Closed Loop Stimulation (CLS)
    • Medellin, Antioquia, Colombia
    • +1 more
    Mar 7, 2022

    Thyroid Gland Carcinoma Trial in Houston (Hyperpolarized Carbon C 13 Pyruvate, Magnetic Resonance Imaging)

    Recruiting
    • Thyroid Gland Carcinoma
    • Hyperpolarized Carbon C 13 Pyruvate
    • Magnetic Resonance Imaging
    • Houston, Texas
      M D Anderson Cancer Center
    Nov 16, 2022

    Advanced Solid Tumors, HER2-positive Breast Cancer Trial in United States (ZN-A-1041 50mg BID, ZN-A-1041 100mg BID, ZN-A-1041

    Recruiting
    • Advanced Solid Tumors
    • HER2-positive Breast Cancer
    • ZN-A-1041 50mg BID
    • +12 more
    • Tucson, Arizona
    • +6 more
    Nov 16, 2022

    Advanced Solid Tumor, CDKN2A, NSCLC Trial (Milademetan, Atezolizumab)

    Withdrawn
    • Advanced Solid Tumor
    • +9 more
    • (no location specified)
    Oct 16, 2023

    Advanced Lung Disease, Lung Transplant, Extracorporeal Membrane Oxygenation Trial in Baltimore (MRP and NMES(neuromuscular

    Active, not recruiting
    • Advanced Lung Disease
    • +2 more
    • MRP and NMES(neuromuscular electric stimulation)
    • Standard of Care
    • Baltimore, Maryland
      University of Maryland
    Dec 8, 2021

    Prostate Cancer Trial in France, Sweden (procedure, biological, device, other)

    Recruiting
    • Prostate Cancer
    • treatment with focal HIFU
    • +6 more
    • Aix-en-Provence, France
    • +14 more
    Mar 15, 2022

    Locally Advanced Esophageal and Gastric Cancers (EGC) Trial in Durham (Pembrolizumab)

    Active, not recruiting
    • Locally Advanced Esophageal and Gastric Cancers (EGC)
    • Durham, North Carolina
      Duke Cancer Center
    Dec 7, 2022

    Pompe Disease (Late-onset) Trial (No Intervention)

    Not yet recruiting
    • Pompe Disease (Late-onset)
    • No Intervention
    • (no location specified)
    Nov 21, 2023